Crossmark

Failure of ceftazidime/avibactam experimental therapy in the treatment of Klebsiella pneumoniae ST11 co-producing NDM-1 and OXA-48 carbapenemases infection

Crossref DOI link: https://doi.org/10.1007/s10096-024-04911-x

Published Online: 2024-07-29

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nikbin, Vajihe Sadat

Gholizadeh Khiavi, Elham Haj Agha

Dehghani-Latani, Mehdi

Hosseinzadeh, Majid

Shirzadi, Mohammad

Pourajam, Samaneh

Nouri, Samereh

Solgi, Hamid
License Information

Text and Data Mining valid from 2024-07-29

Version of Record valid from 2024-07-29
More Information

Article History

Received: 22 April 2024

Accepted: 24 July 2024

First Online: 29 July 2024

Declarations

:

: The study was approved by the Ethical Committee of the Isfahan University of Medical Sciences (approval number IR.ARI.MUI.REC.1401.300). A waiving of the patient informed consent was approved from the Isfahan University Research ethics committee.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below